<style face="normal" font="default" size="100%">ELIGIBILITY VARIES ACROSS THE 3 SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR CARDIOVASCULAR OUTCOMES TRIALS AMONG ADULTS WITH TYPE 2 DIABETES: IMPLICATIONS FROM ANALYSIS OF THE DIABETES COLLABORATIVE REGISTRY</style>

Drupal-Bibcite